Synthesis and anti-H5N1 virus activity of triazole- and oxadiazole-pyrimidine hybrids and their nucleoside analogs. 2020

Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
Photochemistry Department, National Research Centre, Dokki, Giza, Egypt.

New 1,2,3-triazole glycosides and 1,2,4-thioglycosides incorporating a substituted pyrimidinedione ring system were synthesized via click dipolar cycloaddition and heterocyclization of hydrazine-1-carbodithioate derivatives, respectively. The sugar hydrazine derivatives linked aminodimethyluracil were also prepared. In addition, the oxadiazoline substituted with acyclic sugar moieties linked to the pyrimidinedione as acyclic nucleoside analogs were synthesized. The antiviral activity of the synthesized compounds against avian influenza H5N1 virus was investigated and compounds 18, 13 and 19 showed good activities against the virus strains.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D053124 Influenza A Virus, H5N1 Subtype A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 5 and neuraminidase 1. The H5N1 subtype, frequently referred to as the bird flu virus, is endemic in wild birds and very contagious among both domestic (POULTRY) and wild birds. It does not usually infect humans, but some cases have been reported. H5N1 Avian Influenza Virus,H5N1 Bird Flu Virus,H5N1 Virus,H5N1 subtype,H5N1 Viruses,H5N1 subtypes,Virus, H5N1

Related Publications

Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
August 2010, Nucleosides, nucleotides & nucleic acids,
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
November 2017, Molecules (Basel, Switzerland),
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
April 2008, Antimicrobial agents and chemotherapy,
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
January 2019, Chemical & pharmaceutical bulletin,
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
January 2014, Acta poloniae pharmaceutica,
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
July 2017, Nucleosides, nucleotides & nucleic acids,
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
January 1991, Current eye research,
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
August 2022, Chemistry & biodiversity,
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
January 2023, Pharmaceutical research,
Hala E M Tolan, and Wael A El-Sayed, and Nashwa Tawfek, and Farouk M E Abdel-Megeid, and Omnya M Kutkat
January 2001, Cancer chemotherapy and biological response modifiers,
Copied contents to your clipboard!